Expression of Genes Encoding Matrix Metalloproteinases (MMPs) and their Tissue Inhibitors (TIMPs) in Normal and Diseased Canine Mitral Valves

Journal of Comparative Pathology

Volumn 140, Issue 4, 2009, Pages 271-277

  Aupperle, H ^a   Thielebein, J ^b   Kiefer, B ^b   Marz I ^a   Dinges, G ^c   Schoon, H A ^a   Schubert, A ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Tierärztliche Praxis Dr M Wiegand   (Germany)

^d FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

dog; heart valve; matrix metalloproteinase; tissue inhibitor of matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOG DISEASE; ENZYME METABOLISM; GENE EXPRESSION; GENETIC CODE; MITRAL VALVE DISEASE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

CANIS FAMILIARIS;

EID: 63549102220     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.01.001     Document Type: Article

References (23)

1. Aupperle, H., Thielebein, J., Kiefer, B., März, I., Dinges, G. and Schoon, H.-A. An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valve disease (valvular endocardiosis) in dogs. Veterinary Journal, in press, doi:10.1016/j.tvjl.2007.11.011 (epub ahead of print).
2. Bigg H.F., Shi Y.E., Liu Y.E., Steffensen B., and Overall C.M. Specific, high affinity binding of tissue inhibitor of metalloproteinase-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. Journal of Biological Chemistry 272 (1997) 15496-15500
3. Black A., French A.T., Dukes-McEwan J., and Corcoran B.M. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. American Journal of Veterinary Research 66 (2005) 1408-1414
4. Borgarelli M., Zini E., DÁngnolo G., Tarducci A., Santilli R.A., Chiavegato D., Tursi M., Prunotto M., and Häggström J. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. Journal of Veterinary Cardiology 6 (2004) 27-34
5. Buchanan J.W. Chronic valvular disease (endocardiosis) in dogs. Advances in Veterinary Science and Comparative Medicine 21 (1977) 75-108
6. Corcoran B.M., Black A., Dukes McEwan J., French A., Smith P., and Devine C. Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration. American Journal of Veterinary Research 65 (2004) 198-206
7. Dreger S.A., Taylor P.M., Allen S.P., and Yacoub M.H. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. Journal of Heart Valve Disease 11 (2002) 875-880
8. Fondard O., Detaint D., Iung B., Choqueux C., Adle-Biassette H., Jarraya M., Hvass U., Couetil J.-P., Henin D., Michel J.-B., Vahanian A., and Jacob M.-P. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. European Heart Journal 26 (2005) 1333-1341
9. Grüninger B., Schoon H.-A., Schoon D., Menger S., and Klug E. Incidence and morphology of endometrial angiopathies in mares with relationship to age and parity. Journal of Comparative Pathology 119 (1998) 293-309
10. Häggström J., Pedersen H.D., and Kvart C. New insights into degenerative mitral valve disease in dogs. Veterinary Clinics of North America: Small Animal Practice 34 (2004) 1209-1226
11. Hernandez-Barrantes S., Toth M., Bernardo M.M., Yurkova M., Gervasi D.C., Raz Y., Sang Q.A., and Fridman R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Journal of Biological Chemistry 275 (2000) 12080-12089
12. Kogure K. Pathology of chronic mitral valvular disease in the dog. Japanese Journal of Veterinary Science 42 (1980) 323-325
13. Li Y.Y., McTiernan C.F., and Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research 46 (2000) 214-224
14. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., and Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. Journal of Biological Chemistry 272 (1997) 2446-2451
15. Olsen L.H., Mortensen K., Martinussen T., Larsson L.-I., Baandrup U., and Pedersen H.D. Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets. Journal of Comparative Pathology 129 (2003) 120-130
16. Oyama M.A., and Chittur S.V. Genomic expression patterns of mitral valve tissue from dogs with degenerative mitral valve disease. American Journal of Veterinary Research 67 (2006) 1307-1318
17. Peterson J.T., Li H., Dillon L., and Braynt J.W. Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovascular Research 46 (2000) 307-315
18. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., and Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
19. Schneider P., Ernst E., and Trautwein G. Enzyme histocytochemical studies of atrioventricular heart valves in endocardiosis in the dog. Veterinary Pathology 10 (1973) 281-294
20. Soini Y., Satta J., Määttä M., and Autio-Harmainen H. Expression of MMP-2, MMP-9, MTI-MMP, TIMP-1, and TIMP-2 mRNA in valvular lesions of the heart. Journal of Pathology 194 (2001) 225-231
21. Togashi M., Tamura K., Nitta T., Ishizaki M., Sugisaki Y., and Fukuda Y. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves. Pathology International 57 (2007) 251-259
22. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circulation Research 92 (2003) 827-839
23. Whitney J.C. Cardiovascular pathology. Journal of Small Animal Practice 8 (1967) 459-465